Weiwei Zhu, MS

Zhu_Weiwei__205x293.jpg

“I have a longstanding interest in using biostatistics to advance medical research. Working at KPWHRI gives me a great opportunity to contribute to challenging projects with rich, relevant data and make a national impact on health care systems.”

Weiwei Zhu, MS

Biostatistician III, Kaiser Permanente Washington Health Research Institute

Weiwei.Zhu@kp.org
206-442-5215

Biography

Weiwei Zhu, MS, joined Kaiser Permanente Washington Health Research Institute's Biostatistics Unit in 2009. She works closely with Senior Investigator Diana Miglioretti, PhD, to design studies, manage data, and conduct statistical analyses for the Breast Cancer Surveillance Consortium (BCSC)—the National Cancer Institute’s seven-site network of mammography researchers. She has been a key member of the BCSC Statistical Coordinating Center for almost 10 years. Her work studying the breast screening benefits and risks played an essential role in an American Cancer Society screening guideline change in 2015.

Ms. Zhu also works with Senior Investigator Denise Boudreau, PhD, to quantify the serious risks of misuse, abuse, and addiction associated with long-term opioid use.  This multi-site study will use electronic health record data and survey interviews to provide estimates of long-term opioid use risks in two cohorts.

After beginning her medical research career as an intern at the University of Texas MD Anderson Cancer Center in 2007, Ms. Zhu served as a biostatistician at the Moffitt Cancer Center and Research Institute in Florida.

Research interests and experience

 

Recent publications

Hunter S, Love-Jackson K, Abdulla R, Zhu W, Lee JH, Wells KJ, Roetzheim R. Sun protection at elementary schools: a cluster randomized trial. J Natl Cancer Inst. 2010 Apr 7;102(7):484-92. Epub 2010 Mar 23. PubMed

Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, Lopez AS, Koomen J, Engelman RW, Rivera C, Muraoka-Cook RS, Cheng JQ, Schönbrunn E, Sebti SM, Earp HS, Mahajan NP. Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One. 2010 Mar 19;5(3):e9646. PubMed

Wang W, Lau R, Yu D, Zhu W, Korman A, Weber J. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol. 2009 Sep;21(9):1065-77. Epub 2009 Aug 3. PubMed

Tanvetyanon T, Qin D, Padhya T, McCaffrey J, Zhu W, Boulware D, DeConti R, Trotti A. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):687-92. PubMed

Möller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A, Kinal A, Clark GS, Zhu W, Puleo CA, Glass LF, Messina JL, Sondak VK, Cruse CW. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009 Jun;16(6):1526-36. Epub 2008 Dec 3. PubMed

 

Research

Insomnia-phone-therapy-elderly-blog_1col.jpg

Phone therapy for insomnia shown to improve sleep

A study among Kaiser Permanente members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.

News

3-D_Mammography_1col.jpg

Race, income, education affect access to 3D mammography

The technology’s potential benefits to detect breast cancer earlier are not equally shared among all women, researchers find.